slides · global inventory
Turn
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 37,461
Current window 19,711-19,740
Pages 1,249
Rows per page 30
Beat
19,711-19,740 of 37,461
10
The slide presents two side-by-side financial tables detailing inflows, outflows, net flows, realizations, and market activity.Apollo Global Management | Other Presentation Deck | 20 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Benchmark Gap1 hit
11
The slide presents two side-by-side financial tables detailing inflows, outflows, net flows, realizations, and market activity.Apollo Global Management | Other Presentation Deck | 20 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Benchmark Gap1 hit
09
The slide features a stylized silhouette of a human torso with molecular/cellular imagery, likely representing the mechanism of action.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The slide uses a standard clinical trial flow diagram (randomization process).AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Clinical trial baseline characteristics table.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
12
Includes landmark survival rates at 12, 18, and 24 months and time-dependent hazard ratios.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
13
Includes a table of hazard ratios and p-values, and a risk table at the bottom.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
14
Includes Kaplan-Meier plot for DoR and summary tables for ORR and DoR metrics.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
15
Clinical trial safety data table.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The slide uses a dark blue callout box to emphasize the final conclusion/takeaway.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
17
The slide features a stylized silhouette of a human head and torso with internal biological imagery.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
18
The slide uses a standard clinical trial flow diagram (CONSORT-style).AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The slide presents clinical trial baseline data for three cohorts.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
20
Clinical trial data visualization (Kaplan-Meier plot).AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
21
Includes a landmark analysis at 9 months for hazard ratios.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
22
Clinical trial data presentation showing PFS, HR, and TTP metrics.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
23
Clinical trial safety data comparing combination therapy vs monotherapy vs standard of care.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
24
The table displays both 'All grades' and 'Grade ≥3' adverse events for specific medical conditions.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
25
AstraZeneca | Investor Day Presentation Deck | 42 slidesAstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
06
The slide uses a two-column layout: left side shows specific leverage targets, right side lists cash generation sources.Bausch Health Companies | Investor Conference Presentation Deck | 26 slides · Bausch Health
Conference presentation Investor relations Beat · Solution1 hit
07
Bausch Health Companies | Investor Conference Presentation Deck | 26 slidesBausch Health Companies | Investor Conference Presentation Deck | 26 slides · Bausch Health
Conference presentation Investor relations Beat · Solution1 hit
04
The slide uses a linear process flow to differentiate the company's 'Function' focus from the industry standard of 'Sequence' and 'Edit'.Berkeley Lights | Investor Conference Presentation Deck | 22 slides · Berkeley Lights
Conference presentation Investor relations Beat · Solution1 hit
05
The slide uses a three-stage process flow to differentiate Berkeley Lights from competitors in the sequencing and editing markets.Berkeley Lights | Investor Conference Presentation Deck | 22 slides · Berkeley Lights
Conference presentation Investor relations Beat · Solution1 hit
06
Berkeley Lights | Investor Conference Presentation Deck | 22 slidesBerkeley Lights | Investor Conference Presentation Deck | 22 slides · Berkeley Lights
Conference presentation Investor relations Beat · Solution1 hit
07
Berkeley Lights | Investor Conference Presentation Deck | 22 slidesBerkeley Lights | Investor Conference Presentation Deck | 22 slides · Berkeley Lights
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide uses a hub-and-spoke diagram to illustrate the consumer-centric care team.Bright Health Group | Investor Presentation Deck | 17 slides · Bright Health Group
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
08
Uses a hub-and-spoke diagram to illustrate the central role of the company in these three alignment areas.Bright Health Group | Investor Presentation Deck | 17 slides · Bright Health Group
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
09
Bright Health Group | Investor Presentation Deck | 17 slidesBright Health Group | Investor Presentation Deck | 17 slides · Bright Health Group
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
10
Bright Health Group | Investor Presentation Deck | 17 slidesBright Health Group | Investor Presentation Deck | 17 slides · Bright Health Group
Conference presentation Investor relations Beat · Satisfaction1 hit
11
The slide uses a pie chart to contrast Fee-for-Service Medicare vs Medicare Advantage, emphasizing the 61% addressable market.Bright Health Group | Investor Presentation Deck | 17 slides · Bright Health Group
Conference presentation Investor relations Beat · Satisfaction1 hit